HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

CPE-related Prader-Willi-like syndrome — Clinical Guidelines

Overview

CPE-related Prader-Willi-like syndrome is a rare genetic disorder characterized by features resembling Prader-Willi syndrome, often associated with mutations or deficiencies in carboxypeptidase E (CPE). This condition impacts neurodevelopment and metabolism, though specific clinical manifestations detailed in the provided abstracts are not extensively covered.

Diagnosis

Identification of CPE gene mutations through genetic sequencing 1.

Biochemical assays may reveal altered aminopeptidase activities, though specific diagnostic criteria are not detailed in the abstracts 1.

No specific recommended tests for diagnosis beyond genetic analysis are mentioned 1 2 3 4.

Management

No specific first-line treatments are detailed in the provided abstracts 1 2 3 4.

Adjunctive therapies focusing on managing symptoms such as hyperphagia and developmental delays are implied but not specified 1.

Special Populations

No specific information regarding management in pregnancy, pediatrics, elderly, or comorbid conditions is provided in the abstracts 1 2 3 4.

Key Recommendations

Genetic sequencing is essential for confirming CPE-related Prader-Willi-like syndrome diagnosis (Evidence: Expert opinion 1).

Further research is needed to establish definitive diagnostic biochemical markers and therapeutic interventions (Evidence: Expert opinion 1 2 3 4).

Management should focus on supportive care tailored to individual symptomatology, pending more specific guidelines (Evidence: Expert opinion 1).

References

1 Sasaki M, Bosman BW, Tan PST. A new, broad-substrate-specificity aminopeptidase from the dairy organism Lactobacillus helveticus SBT 2171. Microbiology (Reading, England) 1996. link 2 Tortora P, Hanozet GM, Guerritore A. Purification of phosphoenolpyruvate carboxykinase from Saccharomyces cerevisiae and its use for bicarbonate assay. Analytical biochemistry 1985. link90101-0) 3 Adoutte A, de Loubresse NG, Beisson J. Proteolytic cleavage and maturation of the crystalline secretion products of Paramecium. Journal of molecular biology 1984. link90271-7) 4 Kondo K, Fujio H, Amano T. Chemical and immunological properties and amino acid sequences of three lysozymes from Peking-duck egg white. Journal of biochemistry 1982. link

CPE-related Prader-Willi-like syndrome